Investment Team
|
Tony joined Venrock in 1974 and built the firm’s healthcare franchise, helping to shape the modern biotechnology industry. He started his career as a Research Scientist and Group Leader in Organic Chemistry at Union Carbide and as Director of Product Development at Story Chemical. Six of Tony’s portfolio companies have entered the public market in the last three years and over 29 of his investments have been through an IPO during his Venrock tenure. Tony serves as Trustee Emeritus of Princeton University and as a Trustee of The Rockefeller University. Tony is focused on building valuable companies that address important medical needs of the world, while providing strong returns for investors. “The consistent theme of Venrock has been on the people side of the equation, backing great entrepreneurs to build significant companies. We are interested and willing to do new things and follow new pathways. And we operate with the highest level of ethics and social responsibility. Venrock focuses on the entrepreneur as a partner. That is why we’ve been so successful.” "I've been privileged to work with Tony to create 3 biotech ventures, including Infinity Pharmaceuticals. He is a true giant in the biotech industry, investing in companies that transform modern society. Tony has made a distinct contribution to our success. His long term perspective, vision and integrity make him an invaluable asset to Infinity, entrepreneurs and the industry." |
|
||||||||||||
